688506.SHG Sichuan Biokin Pharmaceutical Co. Ltd. A

Healthcare Drug Manufacturers - Specialty & Generic Shanghai Stock Exchange
266.88 CNY
Close of Nov 4, 2026
200.10 404.00
Market cap
CNY 110B
P/E
-
P/B
19.43x
ROE
-17.2%
Dividend yield
0.07%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 688506.SHG undervalued?

Graham number

The Graham number of Sichuan Biokin Pharmaceutical Co. Ltd. A cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sichuan Biokin Pharmaceutical Co. Ltd. A fundamental analysis

No fundamental analysis for Sichuan Biokin Pharmaceutical Co. Ltd. A yet.

Sichuan Biokin Pharmaceutical Co. Ltd. A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sichuan Biokin Pharmaceutical Co. Ltd. A

Sichuan Biokin Pharmaceutical Co.,Ltd. engages in the research and development, manufacture, and sale of biomedicine in the fields of antibody drug conjugate, guidance navigation and control, and antibody radionuclide conjugate in China and internationally. It offers anesthesia, parenteral nutrition, anti-infectives, pediatrics, and traditional Chinese medicines. The company was founded in 1996 and is headquartered in Chengdu, China.

Full company profile